Mature results of the M. D. Anderson Cancer Center risk-adapted transplantation strategy in mantle cell lymphoma

In this study, we analyzed the long-term outcome of a risk-adapted transplantation strategy for mantle cell lymphoma in 121 patients enrolled in sequential transplantation protocols. Notable developments over the 17-year study period were the addition of rituximab to chemotherapy and preparative reg...

Full description

Saved in:

Bibliographic Details
Published in:	Blood Vol. 113; no. 18; p. 4144
Main Authors:	Tam, Constantine S, Bassett, Roland, Ledesma, Celina, Korbling, Martin, Alousi, Amin, Hosing, Chitra, Kebraei, Partow, Harrell, Robyn, Rondon, Gabriela, Giralt, Sergio A, Anderlini, Paolo, Popat, Uday, Pro, Barbara, Samuels, Barry, Hagemeister, Frederick, Medeiros, L Jeffrey, Champlin, Richard E, Khouri, Issa F
Format:	Journal Article
Language:	English
Published:	United States 30.04.2009
Subjects:	Adult Aged Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Combined Modality Therapy Feasibility Studies Female Graft vs Host Disease - therapy Hematopoietic Stem Cell Transplantation Humans Lymphoma, Mantle-Cell - mortality Lymphoma, Mantle-Cell - therapy Male Middle Aged Prognosis Radiotherapy Dosage Retrospective Studies Risk Factors Rituximab Survival Rate Transplantation Conditioning Transplantation, Autologous Treatment Outcome
ISSN:	1528-0020, 1528-0020
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!